Literature DB >> 23339913

Epidemiology of schistosomiasis in Gezira area Central Sudan and analysis of cytokine profiles.

Nagla Mustafa Eltayeb1, Moawia Mohamed Mukhtar, Ahmed Babiker Mohamed.   

Abstract

OBJECTIVE: To determine and compare anti-schistosoma IgG, interleukin-10 (IL-10) and interferon-γ(IFN-γ) levels in the serum of patients and endemic controls and to investigate the epidemiological situation of Al-Hebaika village in the northern part of Gezira Agricultural Irrigation Scheme in 2005.
METHODS: During 2005 survey, serum were collected from 118 villagers. Sixty eight were parasitological positive (patients), and 50 were negative (endemic controls). Indirect ELISA was used to measure and compare the levels of immunoglobulin G (IgG) against Schistsoma mansoni (S. mansoni) soluble worm antigen (SWA) in the patients and endemic control groups from the village and compared with 20 healthy non endemic controls. Sandwich ELISA was also used to measure and compare IL-10 and IFN-γ in the serum of the selected groups.
RESULTS: The overall prevalence of S. haematobium was 20.0% and 0.9% in the first and the second surveys respectively, while the intensity of infection was the same in the two surveys 1.38 [geometric mean egg count (GMFC)]. The overall prevalence of S. mansoni infection was 68.5% and 15.4%, while the intensity of infection was 2.75 (GMEC) and 1.70 (GMEC) in the two surveys respectively. IgG reactivity against SWA showed no significant difference between Schistosoma positive patients and endemic controls. However, there were high significant differences between each of these two groups and the non endemic control group (P= 0,000). Schistosoma patients and exposed controls had significantly higher IL-10 concentration compared with non endemic controls. While endemic controls showed significantly higher IFN-γ concentration than patients (P = 0.000). Also there was very significant difference between IFN-γ levels of each of patients endemic controls and that of the non endemic controls (P = 0.003).
CONCLUSIONS: The study concluded that IFN-γ has a role in the natural resistant to schistosoma mansoni infection. The prevalence and intensity of S. mansoni in the Gezira Irrigation Scheme was greatly reduced. S. haematobium has disappeared from the area.
Copyright © 2013 Hainan Medical College. Published by Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23339913     DOI: 10.1016/S1995-7645(13)60006-1

Source DB:  PubMed          Journal:  Asian Pac J Trop Med        ISSN: 1995-7645            Impact factor:   1.226


  9 in total

1.  Schistosoma mansoni PCR+ -infected individuals in the Sudan present elevated systemic levels of chemokines when compared to uninfected and egg+ cohorts.

Authors:  K Arndts; T E M Elfaki; N Jelden; M Ritter; A Wiszniewsky; G Katawa; I A Goreish; M E Y A Atti El Mekki; M J Doenhoff; A Hoerauf; L E Layland
Journal:  Clin Exp Immunol       Date:  2019-03-19       Impact factor: 4.330

2.  Pattern of infectious diseases among Khalwa (Quran boarding school) students in Khartoum State, Sudan.

Authors:  Almegdad S M Ahmed; Mohammed A Adam; Ahmed A Noureddin; Ahmed A A Mahmoud; Abubaker E A Koko; Mohammed A M A Abdalhameed; Mohammed Elkhalifa; Elfatih M Malik
Journal:  Sudan J Paediatr       Date:  2022

3.  Prevalence, risk factors, and clinical manifestations of schistosomiasis among school children in the White Nile River basin, Sudan.

Authors:  Hassan Ahmed Hassan Ahmed Ismail; Sung-Tae Hong; Azza Tag Eldin Bashir Babiker; Randa Mohamed Abd Elgadir Hassan; Mohammed Ahmed Zakaria Sulaiman; Hoo-Gn Jeong; Woo-Hyun Kong; Soon-Hyung Lee; Han-Ik Cho; Hae-Sung Nam; Chung Hyeon Oh; Young-Ha Lee
Journal:  Parasit Vectors       Date:  2014-10-15       Impact factor: 3.876

4.  Multivariable Regression Analysis in Schistosoma mansoni-Infected Individuals in the Sudan Reveals Unique Immunoepidemiological Profiles in Uninfected, egg+ and Non-egg+ Infected Individuals.

Authors:  Tayseer Elamin Mohamed Elfaki; Kathrin Arndts; Anna Wiszniewsky; Manuel Ritter; Ibtisam A Goreish; Misk El Yemen A Atti El Mekki; Sandra Arriens; Kenneth Pfarr; Rolf Fimmers; Mike Doenhoff; Achim Hoerauf; Laura E Layland
Journal:  PLoS Negl Trop Dis       Date:  2016-05-06

5.  Pattern and outcome of acute kidney injury among Sudanese adults admitted to a tertiary level hospital: a retrospective cohort study.

Authors:  Marwa Osman; Mazin Shigidi; Haider Ahmed; Ihab Abdelrahman; Wieam Karrar; Elhussein Elhassan; Hussam Shwaib; Rayyan Ibrahim; Marwa Abdalla
Journal:  Pan Afr Med J       Date:  2017-09-29

6.  Previous History of American Tegumentary Leishmaniasis Alters Susceptibility and Immune Response Against Schistosoma mansoni Infection in Humans.

Authors:  Guilherme Silva Miranda; Samira Diniz Resende; Diogo Tavares Cardoso; Genil Mororó Araújo Camelo; Jeferson Kelvin Alves Oliveira Silva; Vanessa Normandio de Castro; Stefan Michael Geiger; Mariângela Carneiro; Deborah Negrão-Corrêa
Journal:  Front Immunol       Date:  2021-03-11       Impact factor: 7.561

7.  Association Between the Prevalence of Schistosomiasis in Elementary School Students and Their Parental Occupation in Sudan.

Authors:  Yan Jin; Seungman Cha; Youngjin Kim; Hamdan Mustafa Hamdan; Mousab Siddig Elhag; Hassan Ahmed Hassan Ahmed Ismail; Keon Hoon Lee; Sung-Tae Hong
Journal:  Korean J Parasitol       Date:  2022-02-23       Impact factor: 1.341

Review 8.  Host determinants of reinfection with schistosomes in humans: a systematic review and meta-analysis.

Authors:  Evaristus Chibunna Mbanefo; Nguyen Tien Huy; Anita Akpeedje Wadagni; Christine Ifeoma Eneanya; Obioma Nwaorgu; Kenji Hirayama
Journal:  PLoS Negl Trop Dis       Date:  2014-09-11

9.  Prevalence of schistosomiasis and associated risk factors among school children in Um-Asher Area, Khartoum, Sudan.

Authors:  Khalid Hajissa; Abd Elhafiz M A Muhajir; Hamza Adam Eshag; Alnzer Alfadel; Elkhatieb Nahied; Rabeea Dahab; Safa Mohammed Ali; Marwa Mohammed; Mohamed Gaafar; Zeehaida Mohamed
Journal:  BMC Res Notes       Date:  2018-10-31
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.